🇧🇷 Rhttp1 in Brazil

Rhttp1 (CERLIPONASE ALFA) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Rhttp1 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Brazil

Frequently asked questions

Is Rhttp1 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Rhttp1 in Brazil?

BioMarin is the originator. The local marketing authorisation holder may differ — check the official source linked above.